Velosbio

VelosBio is a next-generation oncology company, developing novel antibody-drug conjugates to treat haematological cancers.

Latest funding

$58M Series A · October 1, 2018

Led by Arix Bioscience · Source: finsmes.com

Latest round on record: Series B+, August 2026, amount undisclosed.

All 2 rounds ↓

Website: velosbio.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Health Care, Medical, Oncology.

Stage: Series B+.

Based in: San Diego, United States.

Founded: 2017.

Last round: Aug 2, 2026 · 102 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Nov 6, 2026.

Signals

Website registeredNov 17, 2017 (9 years old)

TIMELINE · MONEY RAISED

Velosbio | 318 days from website to first raise on record

Raised $58M in 1 sourced round·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

August 2, 2026
Series B+ · amount undisclosed
Source: fundraisingfox.com
October 1, 2018
Series A · $58M
AArix Bioscience (lead), SSofinnova Partners (lead), CChiesi Ventures, DDecheng Capital, PPappas Ventures, TTakeda
Source: finsmes.com
November 17, 2017
Website created

Founders and team

DJ
David Johnson Founder

LinkedIn
SG
Scott Glenn Founder

LinkedIn

Investors

Companies like Velosbio

TTubulis$360M Series B+ · Oct 2025
AAbTx$1.95M Seed · Sep 2026
OOna Therapeutics$86.6M Series B+ · Oct 2026
AAdcytherixSeries A · Oct 2025
AAdcendo$75M Series B+ · Apr 2026
PPanTargPre Seed · Sep 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/velosbio (get a free API key).